You’ve probably seen the headlines or heard the chatter in online wellness groups: the compounded version of tirzepatide, the active ingredient in popular weight loss and diabetes medications, might be going away. If you’re someone who relies on it—or you’ve been thinking about trying it—this news can feel like a punch to the gut. Maybe you’ve finally found something that works, or you’re just starting to explore your options, and now the rug seems to be getting pulled out. It’s confusing, frustrating, and honestly, a little scary. But before you panic, let’s break down what’s actually happening, why compounded tirzepatide exists in the first place, and—most importantly—whether you can still get your hands on it.

What Exactly Is Compounded Tirzepatide?

To understand the current situation, you first need to know what “compounded” means. In simple terms, compounding is the practice of a licensed pharmacist or physician creating a customized version of a medication to meet a specific patient’s needs. Think of it like a tailor-made suit versus something off the rack. The brand-name versions of tirzepatide—sold under names like Mounjaro and Zepbound—are mass-produced, FDA-approved, and have a fixed dosage and formulation. But a compounded version is prepared by a compounding pharmacy, often in a slightly different strength, without certain inactive ingredients, or sometimes even combined with other vitamins or supplements.

Compounded tirzepatide gained massive popularity for one simple reason: cost and availability. The brand-name injectors can run you over a thousand dollars a month if your insurance doesn’t cover them, and during the height of the demand surge, many people couldn’t even find them in stock. Compounded versions offered a more affordable, accessible alternative. But because they aren’t FDA-approved, they exist in a bit of a gray area—regulated by state pharmacy boards instead of the federal drug agency, and allowed only under specific circumstances.

The Shortage That Changed Everything

The whole story hinges on a drug shortage. When the FDA lists a medication as “in shortage,” it opens a legal loophole that allows compounding pharmacies to make essentially identical copies of the drug without going through the normal approval process. This is perfectly legal under the Federal Food, Drug, and Cosmetic Act, as long as the pharmacy follows strict compounding standards. For tirzepatide, that shortage has been ongoing for over a year, which is why compounded versions have been so widely available.

But here’s the catch: shortages don’t last forever. The manufacturer, Eli Lilly, has been ramping up production, and as of early 2024, the FDA has started to declare the shortage resolved. Once that happens, the loophole closes. In fact, the FDA has already removed tirzepatide from its shortage list for certain doses, and the agency has made it clear that compounding pharmacies are expected to stop mass-producing copies once the supply is stable.

That said, “resolved” doesn’t mean “instantly gone.” The FDA has given pharmacies a transition period—usually a few months—to wind down their production. So even if you’re reading this right now, there’s a good chance you can still get compounded tirzepatide, but the window is narrowing.

Can You Still Get It Right Now?

The short answer is: yes, probably, but it depends on where you live and who you’re working with. Many compounding pharmacies are still producing tirzepatide, especially for doses that remain in shortage or for patients who have specific medical needs that the brand-name version can’t meet. For example, if you have a documented allergy to an inactive ingredient in the name-brand injector, a compounding pharmacy can legally make you a version without it. That’s not a loophole—that’s legitimate, patient-specific compounding, and it’s always allowed.

However, the days of easily ordering compounded tirzepatide from an online telehealth provider with just a quick questionnaire may be numbered. Those services rely on the bulk-production exception created by the shortage. Once that’s gone, many of them will have to stop offering it. So if you’re currently using one of those services, now is the time to ask questions and plan ahead.

What Are Your Options Moving Forward?

Let’s be realistic: the landscape is shifting, but you’re not out of options. Here’s what you can do right now to stay ahead of the curve:

  • Talk to your prescriber. If you’re already on compounded tirzepatide, have an honest conversation with your doctor about what happens next. They may be able to switch you to the brand-name version or help you find a local compounding pharmacy that can legally prepare a personalized formulation for you.
  • Check your insurance coverage. You might be surprised. Many insurance plans have started covering Mounjaro or Zepbound for weight loss, especially if you have a diagnosis like obesity or type 2 diabetes. Call your insurance company directly and ask about prior authorization requirements and out-of-pocket costs.
  • Look into manufacturer savings programs. Eli Lilly offers savings cards and patient assistance programs that can bring the cost of brand-name tirzepatide down significantly—sometimes to as little as $25 a month if you qualify.
  • Consider alternative GLP-1 medications. If tirzepatide becomes too expensive or hard to find, semaglutide (the active ingredient in Ozempic and Wegovy) is another highly effective option. It’s been around longer, and while it also has compounding and shortage issues, it might be more readily available through traditional channels.
  • Stock up if you can. Some compounding pharmacies are allowing patients to refill their prescriptions early or get a 90-day supply. This isn’t always possible, but it’s worth asking your pharmacy about their policy.

A Word of Caution

As the compounded tirzepatide market tightens, you might see more sketchy offers popping up online—unlicensed sellers, “research peptides,” or products sold without a prescription. Please, steer clear. These products are not regulated, may contain dangerous impurities, and could have unpredictable potency. Your health is worth more than a discount. Stick with licensed compounding pharmacies that are accredited by organizations like the Pharmacy Compounding Accreditation Board, and always work with a licensed healthcare provider who can monitor your progress.

The Bottom Line

So, can you still get compounded tirzepatide? For now, yes, but the clock is ticking. The shortage is ending, and with it, the easy access we’ve enjoyed over the past year. But that doesn’t mean you’re out of options. Whether you switch to the brand-name version, explore other medications, or work with a local pharmacy for a truly customized compound, there are paths forward. The key is to act proactively—don’t wait until your last vial is gone. Talk to your doctor, check your insurance, and make a plan. The world of weight loss and diabetes management is changing fast, but with a little foresight, you can stay one step ahead.